Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.8 USD | +0.03% | -0.82% | -4.82% |
May. 09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
May. 08 | Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 182B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.18B | EV / Sales 2024 * | 4.5 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 640M | EV / Sales 2025 * | 4.06 x |
P/E ratio 2024 * |
30.6
x | P/E ratio 2025 * |
26.1
x | Employees | 114,000 |
Yield 2024 * |
2.07% | Yield 2025 * |
2.21% | Free-Float | 86.96% |
Latest transcript on Abbott Laboratories
1 day | +0.03% | ||
1 week | -0.82% | ||
Current month | -1.13% | ||
1 month | -3.98% | ||
3 months | -5.90% | ||
6 months | +9.37% | ||
Current year | -4.82% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 17 M€ | +6.46% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 104.8 | +0.03% | 5,459,183 |
24-05-10 | 104.7 | +0.07% | 7,349,729 |
24-05-09 | 104.7 | -0.26% | 5,902,240 |
24-05-08 | 104.9 | -1.16% | 6,234,711 |
24-05-07 | 106.2 | +0.50% | 6,556,396 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.07% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+14.73% | 25.32B | |
-1.73% | 24.6B |
- Stock Market
- Equities
- ABT Stock